Article

AAO 2019 Retina Street Team: Allen C. Ho, MD

Author(s):

AAO 2019 Retina Street Team

Allen C. Ho, MD, discusses precision subretinal delivery for gene and cell therapy along with Ben Ko, engineering manager, Kaleidoscope Innovation, at the 2019 meeting of the American Academy of Ophthalmology in San Francisco, CA.

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Related Content
FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
March 6th 2025

FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Cigarette smoking linked to reduced choroidal vascularity
March 4th 2025

Cigarette smoking linked to reduced choroidal vascularity

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies
February 28th 2025

Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies

RetinalGenix Technologies begins testing remote ocular monitoring system
February 27th 2025

RetinalGenix Technologies begins testing remote ocular monitoring system

© 2025 MJH Life Sciences

All rights reserved.